Genetics of diabetic nephropathy: Evidence for major and minor gene effects

Kidney International

Volumn 55, Issue 4, 1999, Pages 1582-1596

  Krolewski, Andrzej S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

ACE gene; Angiotensinogen gene; AT1 gene; Diabetes mellitus; Heredity; Proteinuria

Indexed keywords

ANGIOTENSINOGEN;

ADULT; CASE REPORT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GENE LOCUS; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

EID: 0032895814     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00371.x     Document Type: Review

References (96)

1. ROSSING P, HOUGAARD P, BORCH-JOHNSEN K, PARVING HH: Predictors of mortality In insulin dependent diabetes: 10 year observational follow-up study, BMJ 313:779-784, 1995
2. MIETTINEN H, HAEESER SM, LEHTO S, RONNEMAA T, PYORALA K, LAAKSO M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabotic subjects. Stroke 27:2033-2039, 1996
3. DDCT RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control und Complications Trial. N Engl J Med 329:977-986, 1993
4. SAVAGE S, JOHNSON NAGEL N, ESTACIO RO, LUKKEN N, SCHRIER RW: Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 25:836-844, 1995
5. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985
6. QUINN M, ANGELICO MC, WARRAM JH, KROLEWSKI AS Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diubetologia 39:940-945, 1996
7. KUOURY MJ, BENTY TH, LIANG KY: Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 127:674-683, 1988
8. SEAQUIST ER, GOFTZ FC, RICH SS, BARBOSA J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. W Engl J Med 320:1161-1165, 1989
9. BORCH-JOHNSEN K, NORGAARD K, HOMMEL E, MATHIESON ER, JENSEN JS, DECKERT T, PARVING HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
10. DCCT RESEARCH GROUP: Clustering of long-term complications in families with diabetes in the Diabetes Control und Complications Trial. Diabetes 46:1829-1839, 1997
11. KROLEWSKI AS, DORIA A, MAGRE J, WARRAM JH, HOUSMAN D: Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus. J Am Soc Nephrol 3:S9-S18, 1992
12. KROLEWSKI AS, LAFFEL LMB, KROLEWSKI M, QUINN M, WARRAM JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
13. KHOURY M, BEATY T, COHEN B (editors): Fundamentals of Genetic Epidemiology. New York, Oxford University Press, 1993. pp 233-283
14. RISCH N: Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46:222-228, 1990
15. ROGUS JJ, KROLEWSKI AS: New development in the search for diabetic nephropathy susceptibility genes. Diabetes Annu 11:49-61, 1998
16. ROGUS JJ, KROLEWSKI AS: Using discordant sib-pairs to map loci for qualitative traits with high sibling recurrence risk. Am J Hum Genet 59:1376-1381, 1996
17. SPIELMAN RS, MCGINNIS RE, EWENS WJ: Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516, 1993
18. MOCZULSKI DK, ROGUS JJ, ANIONELLIS A, WARRAM JH, KROLEWSKI AS: Major susceptibility locus for nephropathy in type 1 diabetes mellitus on chromosome 3q: Results of novel discordant sib-pair analysis. Diabetes 47:1164-1169, 1998
19. FOGARTY DG, HARRON JC, HUGHES AE, NEVIN NC, DOHERTY CC, MAXWELL AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45:1204-1208, 1996
20. TARNOW L, CAMBIEN F, ROSSING P, NIELSEN FS, HANSEN BV, RICARD S, POIRIER O, PARVING HH: Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 45:367-369, 1996
21. DORIA A, ONUMA T, GEARIN G, FREIRE MBS, WARRAM JH, KROLEWSKI AS: Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 27:1134-1139, 1996
22. CHOWDHURY TA, DRONSFIELD MJ, KUMAR S, GOUGH SL, GIBSON SP, KHATOON A, MACDONALD F, ROWE BR, DUNGER DB, DEAN JD, DAVIES SJ, WEBBER J, SMITH PR, MACKIN P, MARSHALL SM, ADU D, MORRIS PJ, TODD JA, BARNETT AH, BOULTON AJ, BAIN SC: Examination of two genetic polymorphisms within the renin-angiotensin system. No evidence for an association with nephropathy in IDDM. Diabetologia 39:1108-1114, 1996
23. RINGEL J, BEIGT J, KUNZ R, DISTLER A, SHARMA AM: Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 40:193-199, 1997
24. MARRE M, BERNADET P, GALLUIS Y, SAVAGNER F, GUYENE TT, HALLAB M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, diabetic retinal and renal complications. Diabetes 43:384-388, 1994
25. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of the angiotensin I converting enzyme gene. Diabetes 43:690-695, 1994
26. TARNOW L, CAMBIEN F, ROSSING P, NIELSEN FS, HANSEN BV, LECERE L, POIRIER O, DANILOV S, PARVING HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
27. SCHMIDT S, SCHONE N, RITZ E, AND THE DIABETIC NEPHROPATHY STUDY GROUP: Association of ACE gene polymorphism and diabetic nephropathy. Kidney Int 47:1176-1181, 1995
28. BARNAS U, SCHMIDT A, ILLIEVICH A, KIENER HP, RABENSTEINER D, KAIDER A, PRAGER R, ABRAHAMIAN H, IRSIGLER K, MAYER G: Evaluation of risk factors for the development of nephropathy in patients with IDDM: Insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 40:327-331, 1997
29. MARRE M, JEUNEMAITRE X, GALLOIS Y, RODIER M, CHATELLIER G, SERT C, DUSSELIER L, KAHAL Z, CHAILIOUS L, HALIMI S, MULLER A, SACKMANN H, BAUDUCEAU B, BLED F, PASSA P, ALHENC-GELAS F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585-1595, 1997
30. FUJISAWA T, IKEGAMI H, KAWAGUCHI Y, HAMADA Y, UEDA H, SHINTANI M, FUKUDA M, OGIHARA T: Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41:47-53, 1998
31. ROGUS JJ, MOCZULSKI DK, FREIRE MB, YANG Y, WARRAM JH, KROLEWSKI AS: Diabetic nephropathy is associated with AGT polymorphism T235: Results of a family-based study. Hypertension 31:627-631, 1998
32. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV Y, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUL JM, CORVOL P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-178, 1992
33. SCHMIDT S, SHARMA AM, ZILCH O, BEIGE J, WALLA-FRIEDEL. M, GANTEN D, DISTLER A, RITZ E: Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 10:1145-1148, 1995
34. PENNO G, CHATURVEDI N, TALMUD PJ, COTRONEO P, MANTO A, NANNIPIERI M, LUONG LA, FULLER JH: The effect of angiotensin converting enzyme gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: Findings from the EUCLID randomized controlled trial. Diabetes 47:1507-1511, 1998
35. SCHACHTER F, FAURE-DELANEF L, GUENOT F, ROUGER H, FROGUEL P, LESUEUR-GINOT L, COHEN D: Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6:29-32, 1994
36. GALINSKY D, TYSOE C, BRAYNE CE, EASTON DF, HUPPERT FA, DENING TR, PAYKEI ES, RUBINSZTEIN DC: Analysis of the apo E/ apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 129:177-183, 1997
37. HIBBERD ML, MILLWARD BA, DEMAINE. AG: The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. J Diabetes Complications 11:2-8, 1997
38. COLLINS FS: Positional cloning moves from perditional to traditional. Nat Genet 9:347-350, 1995
39. JENKINS DA, COWAN P, COLLIER A, WATSON ML, CLARKE BF: Blood glucose control determines the renal haemodynamic response to angiotensin converting enzyme inhibition in type I diabetes. Diabet Med 9:252-259, 1990
40. WILLIAMS GH, DLUHY RG, LIFTON RP, MOORE TJ, GLEASON R, WILLIAMS R, HUNT SC, HOPKINS PN, HOLLENBERG NK: Non-modulation as an intermediate phenotype in essential hypertension. Hypertension 20:788-796, 1992
41. HOLLENBERG NK: Genes, hypertension, and intermediate pheno types. Curr Opin Cardiol 11:457-463, 1996
42. DERUBERTIS FR, CRAVEN PA: Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
43. KING GL, ISHH H, KOYA D: Diabetic vascular dysfunctions: A model of excessive activation of protein kinase C. Kidney Int 60(Suppl):S77-S85, 1997
44. BAYNES JW:Role of oxidative stress in the development of complications in diabetes. Diabetes 40:405-412, 1991
45. WILLIAMSON JR, CHANG K, FRANGOS M, HASAN KS, IDO Y, KAWAMURA T, NYENGAARD JR, VAN DEN ENDEN M, KILO C, TILION RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
46. SALAHUDEEN AK, KANJI V, RECKELHOFF JF, SCHMIDT AM: Pathogenesis of diabetic nephropathy: A radical approach. Nephrol Dial Transplant 12:664-668, 1997
47. BROWNLEE M, LILLY LECTURE 1993: Glycation and diabetic complications. Diabetes 43:836-841, 1994
48. VLASSARA H: Protein glycation in the kidney: Role in diabetes and aging Kidney Int 49:1795-1804, 1996
49. ZIYADEH FN, COURS MP: Effects of glycated albumin on mesangial cells: Evidence for a role in diabetic nephropathy. Mol Cell Biochem 125:19-25, 1993
50. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic susceptibility to nephropathy in insulin-dependent diabetes: From epidemiology to molecular genetics. Diabetes Metab Rev 11:287-314, 1995
51. FREEDMAN BI, SPRAY BJ, TUTTLE AB, BUCKALEW VM: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21:387-393, 1993
52. BROWN DM, PROVOOST AP, DALY MJ, LANDER ES, JACOB HJ: Renal disease susceptibility and hypertension are under independent genetic control In the fawn-hooded rat, Nat Genet 12:44-51, 1996
53. BILOUS RW, MAUER SM, SUTHERLAND DE, STEFFES MW: Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes 38:1142-1147, 1989
54. JEUNEMATTRE X, INOUE I, WILLIAMS C, CHARRU A, TICHET J, POWERS M, SHARMA AM, GIMENEZ-ROQUEPLO AP, HATA A, CORVOL P, LALOUEL. JM: Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 60:1448-1460, 1997
55. INOUE I, NAKAJIMA T, WILLIAMS CS, QUACKENBUSH J, PURYEAR R, POWERS M, CHENG T, LUDWIG EH, SHARMA AM, HATA A, JEUNEMAITRE X, LALOUEL JM: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797, 1997
56. HOPKINS PN, LIFTON RP, HOLLENBERG NK, JEUNEMAITRE X, HALLOUIN MC, SKUPPIN J, WILLIAMS CS, DLUBY RG, LALOUEL JM, WILLIAMS RR, WILLIAMS GH: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 14:199-207, 1996
57. VILLARD E, SOUBRIER F: Molecular biology and genetics of the angiotensin-I-converting enzyme: Potential implications in cardiovascular diseases. Cardiovasc Res 32:999-1007, 1996
58. VILLARD E, TIRET L, VISVIKIS S, RAKOTOVAO R, CAMBIEN F, SOUBRIER F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 58:1268-1278, 1996
59. PANABLOO A, ANDRES C, MOHAMED-ALI V, GOULD MM, TALMUD P, HUMPHRIES SE, YUDKIN JS: The insertion allele of the ACE gene I/D polymorphism: A candidate gene for insulin resistance? Circulation 92:3390-3393, 1995
60. CHIU MC, MCCARTHY JE: The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance. Metabolism 46:395-399, 1997
61. MILLER JA, SCHOLEY JW, THAI K, PEI YP: Angiotensin converting enzyme gene polymorphism and remit hemodynamic function in early diabetes. Kidney Int 51:119-124, 1997
62. HUMPHREY LL, BALLARD DJ, FROHNERI PP, CHU CP, O'FALLON M. PALUMBO PJ: Chronic renal failure in non-insulin-dependent diabetes mellitus: A population based study in Rochester, Minnesota. Ann Intern Med 111:788-796, 1989
63. PETTITI DJ, SAAD MF, BENNETI PH, NELSON RG, KNOWLER WC: Familial predisposition to renal disease in two generations of Pima Indians with type II (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
64. FREEDMAN BI, TUTTLE. AB, SPRAY BJ: Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 25:710-713, 1995
65. FARONATO PP, MAIOLL M, TONOLO G, BROCCO E, NOVENTA F, PIARULLI F, ABARTERUSSO C, MODENA F, DE BIGONTINA G, VELUSSI M, INCHIOSTRO S, SANTEUSANIO F, BUETI A, NOSADINI R: Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM nephropathy study group. Diabetologia 40:816-823, 1997
66. NELSON RG, SAAD MF, KNOWLER WC, BENNETI PH, PETTITI DJ: Diabetic kidney disease in Pima Indians. Diabetes Care 16:335-341, 1993
67. COWIE CC, PORT FK, WOLFE RA, SAVAGE PJ, MOLL PP, HAWTHORNE VM: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321:1074-1079, 1989
68. BRANCATI FL, WHITTLE: JC, WHELTON PK, SEIDLER AJ, KLAG MJ: The excess incidence of diabetic end-stage renal disease among blacks: A population-based study of potential explanatory factors. JAMA 268:3079-3084, 1992
69. BALLARD DJ, HUMPHREY LL, MELTON LJ, FROHNERT PP, CHU PC, O'FALLON WM, PALUMBO PJ: Epidemiology of persistent proteinuria in type II diabetes mellitus: Population based study in Rochester, Minnesota. Diabetes 37:405-412, 1988
70. KLEIN R, KLIEN BE, MOSS SE: Incidence of gross proteinuria in older-onset diabetes: A population-based perspective. Diabetes 42:381-389, 1993
71. IMPERATORE G, HANSON RL, PETTITI DJ, KNOBES S, BENNETT PH, KNOWLER WC: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes mellitus. Diabetes 47:821-830, 1998
72. YU H, BOWDEN DW, SPRAY BJ, RICH SS, FREEDMAN BI: Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol 7:2259-2264, 1996
73. DUDLEY CR, KEAVNEY B, SIRATION IM, TURNER RC, RATCLIFFE PJ: UK prospective diabetes study: XV. Relationship of renin-angiotensin study gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48:1907-1911, 1995
74. JEFFERS BW, ESTACIO RO, RAYNOLDS MV, SCHRIER RW: Angiotonsin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 52:473-477, 1997
75. FREIRE MBS, JI L, ONUMA T, ORBAN T, WARRAM JH, KROLEWSKI AS: Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 31:896-899, 1998
76. SPIELMAN RS, EWENS WJ: A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test. Am J Hum Genet 62:450-458, 1998
77. BOIESTIG, M, ARNQVIST HJ, HERMANSSON G, KARI BERG BE, LUDVIGSSON J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18, 1993
78. KROLEWSKI M, EGGERS P, WARRAM JH: Magnitude of end-stage renal disease in IDDM: A 35 year follow-up study. Kidney Int 50:2041-2046, 1996
79. KROLEWSKI AS, CANESSA M, WARRAM JH, LAFFEL LM, CHRISTLIER AR, KNOWLER WC, RAND LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
80. VIBERTI GC, KEEN H, WISEMAN MJ: Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. BMJ 295:515-517, 1987
81. BARZILAY J, WARRAM JH, BAK M, LAFFEL L, CANESSA M, KROLEWSKI AS: Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. Kidney Int 41:723-730, 1992
82. + antiporter phenotype and turnover of immortalized lymphoblasts from type I diabetic patients with nephropathy. J Clin Invent 93:2750-2757, 1994
83. MANGILI R, BENDING JJ, SCORI G, LI LK, GUPTA A, VIBERTI GC: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 318:146-150, 1988
84. + antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41:1239-1246, 1992
85. FAGERUDD JA, TARNOW L, JACOBSEN P, STENMAN S, NIELSEN FS, PETTERSSON-FERNHOLM KJ, GRONGHAGEN-RISKA C, PARVING HH, GROOP PH: Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 47:439-444, 1998
86. RUDBERG S, STATTIN EL, DAHLOUIST G: Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients. Diabetes 47:1121-1126, 1998
87. + antiport activity in type I (insulin-dependent) diabetic patients with nephropathy. Diabetologia 33:371-377, 1990
88. + antiporter. Kidney Int 50:1684-1693, 1996
89. ROSSKOPE D, DUSING R, SIFFERT W: Membrane sodium-proton exchanger and primary hypertension. Hypertension 21:607-617, 1993
90. + antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension 25:971-977, 1995
91. SIFFERT W, ROSSKOPF D, MORITZ A, WIELAND T, KALDENBERG-STASCH S, KETTLER N, HARTUNG R, BECKMANN S, JAKOBS KH: Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 96:759-766, 1995
92. PIETRUCK F, SPLETTER S, DAUL A, PHILIPP T, DERWATH. M, SCHATZ H, SIFFERT W: Enhanced G protein activation in IDDM patients with diabetic nephropathy. Diabetologia 41:9-4-100, 1998
93. SIFFERT W, ROSSKOPF D, SIFFERT G, BUSCH S, MORITZ A, ERBEL R, SHARMA AM, RITZ E, WICHMANN HE, JAKOBS KH, HORSTHEMKE B: Association of a human G-protein β3 subunit variant with hypertension. Nature Genet 18:45-48, 1998
94. FOGARTY DG, ZYCHMA MJ, SCOTI L, WARRAM JH, KROLEWSKI AS: Polymorphism in the human G-protcin β3 subunit gene and diabetic nephropathy in IDDM. Diabetologia 41:1304-1308, 1998
95. DORIA A, ONUMA T, WARRAM JH, KROLEWSKI AS: Synergistic effect of angiotensin II type I receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 40:1293-1299, 1997
96. KROLEWSKI AS, WARRAM JH, RAND LI, KAHN CR: Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-1398, 1987